Stocks Archives - Page 26 of 35

drug discovery, drug discovery outsourcing, CRO, CDMO, CRAMS

Categories

Prime Stock recommendation : A preferred partner for drug discovery outsourcing

The company we have recommended is assisting global bio-pharmaceutical companies in the end-to-end process of drug discovery to manufacturing. There is an increasing trend within the global life sciences industry to partner with integrated contract research organisations that can provide customised and end-to-end solutions to both large conglomerates to young startup biotechs.

Premium article available only to registered users.

N V Chandrachoodamani January 25, 2022 No Comments

Categories

Interest rates: Should you move out of equities?

Long-standing warnings by market gurus about the imminent popping of the stock market bubble seemed to come good, with interest rates for US treasuries spiking up sharply and triggering a fairly sharp correction in stock prices across the world. But why should stocks fall if interest rates rise and will such a rate hike impact India?

R Balakrishnan January 23, 2022 2 Comments

Stocks

The magic formula to identify multi-bagger stocks

Bull markets are always decked with stories of compounders and multi-bagger stocks, pushing investors to hunt for multi-bagger stocks in every investment they make. But as many of us know, very few companies end up delivering such high returns, over a sustained period.

N V Chandrachoodamani January 13, 2022 No Comments

Categories

Prime Equity Outlook 2022

Prime Equity Outlook 2022
It’s a little difficult to be optimistic about the year ahead when news headlines and social media debates are all about Covid counts and the mysterious symptoms of Omicron (or is it Deltacron?). Indeed, as we write this, two-thirds of PrimeInvestor’s tiny team has also been struck down by Covid-ish symptoms.

Aarati Krishnan January 11, 2022 13 Comments

Categories

Technical outlook: Short-term outlook for Nifty 50 & key sectors

let’s take a look at whether the short-term outlook for Nifty 50 holds or has changed. The Nifty 50 was unable to clear this resistance and was rejected from this level.

B Krishnakumar January 2, 2022 7 Comments

Categories

Prime Stocks performance review – 2021

It is with mixed feelings that we write this first annual review of our Prime Stocks performance. When we flagged off stock recommendations as a new addition to our platform on January 14 2021, it was after a lot of internal debate on whether it was the right time to do this.

PrimeInvestor Research Team December 28, 2021 22 Comments

Stocks

Prime Stocks 2021 review: How earnings shaped up & stock outlook

In our stock recommendations for 2021, our focus was on identifying companies that had the ability to steadily compound earnings over the medium to long term. Valuations were the other key factor against which we balanced earnings.

PrimeInvestor Research Team December 28, 2021 No Comments

Stocks

The pros and cons of stock SIPs

With more retail investors wanting to get in on the action happening in the stock markets, SIP in stocks have been gaining popularity as it allows investors to buy stocks in reasonable quantities with time, even if they cannot spare a large sum in one go. What is an SIP in stocks, how does it work, how does an SIP in stocks stack up against a lump sum investment? Should you make an SIP in stocks your preferred route to investing in equity?

Anush Raj P December 21, 2021 No Comments

Categories

After the correction, what’s next for Nifty 50?

After the correction, what’s next for Nifty 50? In our previous post on the outlook for the Nifty 50 index, we had shared the view that the correction in the Nifty 50 was incomplete, and we were making a case for a bounce to a lower high and one more push lower.

B Krishnakumar December 12, 2021 5 Comments

Stocks

What are high beta stocks

The very term ‘high beta stocks’, sounds exciting and adrenaline packed – well at least as far as investing goes. But how should beta be interpreted, what are high beta stocks and should high beta stocks find a place in your portfolio? These are some of the questions that this article delves into.

Pavithra Jaivant December 12, 2021 No Comments

Categories

Diagnostics sector review – is it a high growth sector to watch?

Here is a look at the diagnostics sector space, the key players, how they have weathered the Covid storm and, more importantly, where it could be headed.

Pavithra Jaivant December 5, 2021 2 Comments

Categories

The planned split in the Godrej Group: What to expect

One such reputed family-owned business empire in India has been the Godrej group, founded in 1897. Starting from “lock” manufacturing, the company diversified into soap manufacturing in 1928 (from vegetable oils) and then to animal feeds, real estate, processed foods and chemicals.

N V Chandrachoodamani November 30, 2021 No Comments

PrimeInvestor - Articles and Reports

Prime Stock recommendation : A preferred partner for drug discovery outsourcing

Interest rates: Should you move out of equities?

The magic formula to identify multi-bagger stocks

Prime Equity Outlook 2022

Technical outlook: Short-term outlook for Nifty 50 & key sectors

Prime Stocks performance review – 2021

Prime Stocks 2021 review: How earnings shaped up & stock outlook

The pros and cons of stock SIPs

After the correction, what’s next for Nifty 50?

What are high beta stocks

Diagnostics sector review – is it a high growth sector to watch?

The planned split in the Godrej Group: What to expect

Login

Become a PrimeInvestor!

Login

Become a PrimeInvestor!